We serve Chemical Name:1-(3-bromophenyl)piperidin-4-amine CAS:1179833-02-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:1-(3-bromophenyl)piperidin-4-amine
CAS.NO:1179833-02-3
Synonyms:1-(3-bromophenyl)piperidin-4-amine
Molecular Formula:C11H15BrN2
Molecular Weight:255.15400
HS Code:2933399090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:29.26000
Exact Mass:254.04200
LogP:3.14190
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 1-(3-bromophenyl)piperidin-4-amine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-(3-bromophenyl)piperidin-4-amine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-(3-bromophenyl)piperidin-4-amine Use and application,1-(3-bromophenyl)piperidin-4-amine technical grade,usp/ep/jp grade.
Related News: As you can see, a considerable number of staff is involved in the production phase until an API is finally manufactured. 1-(3-bromophenyl)piperidin-4-amine manufacturer Government officials say that the number of visitors from the mainland and other countries has decreased significantly after they closed several border points and rail stations and cut flight arrivals by half. 1-(3-bromophenyl)piperidin-4-amine supplier The FDA also said that the labeling of the diagnostic, which comes in different versions, included performance claims that did not match up with results seen in clinical studies—and that the data Innova submitted for review “was identical to data previously provided by other manufacturers” in separate requests for emergency COVID authorizations, raising additional questions. 1-(3-bromophenyl)piperidin-4-amine vendor The United States has suspended imports of dogs from more than 100 countries where there’s a high rabies risk. 1-(3-bromophenyl)piperidin-4-amine factory When they do design their phase 3, they’re going to need to be better about that part of the study design, and really focus on enrolling individuals that have the right biomarkers to be able to look at not only the safety and tolerability but also the efficacy on cognition and function,” Edelmayer said.
The vaccine approach is promising because using the body’s immune system to fight Alzheimer’s would sidestep one of the problems in developing a drug to treat the disease — namely that it’s difficult to design medications that can easily enter the brain and attack a specific target, Edelmayer explained.
Through booster doses given every three months, the vaccine is “training your body over time how to react to the pathological tau,” Edelmayer said. “You will likely need additional shots of this particular therapeutic to keep it as productive as possible in targeting that tau.
The vaccine approach is promising because using the body’s immune system to fight Alzheimer’s would sidestep one of the problems in developing a drug to treat the disease — namely that it’s difficult to design medications that can easily enter the brain and attack a specific target, Edelmayer explained.
Through booster doses given every three months, the vaccine is “training your body over time how to react to the pathological tau,” Edelmayer said. “You will likely need additional shots of this particular therapeutic to keep it as productive as possible in targeting that tau.
